David Hung - 05 Jun 2024 Form 4 Insider Report for NovoCure Ltd (NVCR)

Role: Director
Signature: Ovie Onobrakpeya, as attorney in fact for Hung, David
Issuer symbol: NVCR
Transactions as of: 05 Jun 2024
Net transactions value: $0
Form type: 4
Filing time: 06 Jun 2024, 17:55:35 UTC
Previous filing: 04 Mar 2024
Next filing: 04 Mar 2025
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	NVCR	Restricted Stock Units	Award	$0	+4,053	+44%	$0.000000	13,194	05 Jun 2024	Direct	F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	NVCR	Stock Option (Right to Buy)	Award	$0	+6,229		$0.000000	6,229	05 Jun 2024	Ordinary Shares	6,229	$23.13	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These restricted stock units are scheduled to vest 100% on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.
F2	Options to buy 6,229 ordinary shares will fully vest and become exercisable on the earlier of the following dates: (i) the first anniversary of the grant date or (ii) the day immediately preceding the Company's 2025 annual general meeting of shareholders.